Results 181 to 190 of about 11,862,425 (370)

Publication bias in clinical research

The Lancet, 1991
A. M. Gülmezoglu, Andrew Vickers, A. Chan, B. Djulbegovic, David Moher, David W Howells, Davina Ghersi, D. Altman, Elaine Beller, Elina Hemminki, Elizabeth Wager, Fujian Song, B. Worp, H. Krumholz, Iain Chalmers, Ian Roberts, Isabelle Boutron, Janet Wisely, J. Ioannidis, J. Grant, Jonathan Kagan, Julian Savulescu, K. Dickersin, K. F. Schulz, Malcolm R. Macleod, M. Hlatky, Michael B Bracken, Muin Mike Clarke, J. Khoury, P. Bossuyt, Paul Glasziou, P. Gøtzsche, Robert S Phillips, Robert Tibshirani, ‐. RustamAl, Shahi Salman, Sander Greenland, Sandy Oliver, Silvio Garattini, Steven Julious, Susan Michie, Tom Jefferson, Ulrich Dirnagl   +42 more
semanticscholar   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Other Publications of Interest to Academic Librarians

, 1977
American Library Association
openalex   +2 more sources

ICRP Publication 135: Diagnostic Reference Levels in Medical Imaging

Annals of the ICRP, 2017
E. Vañó, D. Miller, C. Martin, Madan M. Rehani, K. Kang, M. Rosenstein, P. Ortiz-López, S. Mattsson, R. Padovani, A. Rogers   +9 more
semanticscholar   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Publications récentes [PDF]

, 2014
R, Harold Roberts, Sheldon Zalkind, Timothy Costello, Economie Malley, Humanisme, H Stanley, Ydy, Joseph Lapreato, James Clark, Robert Syndicalisme, Pottier, Kurt Hanslowe   +12 more
openalex   +1 more source

Strategy publication [PDF]

, 2014
Bourdeix, Roland, Prades, Alexia
core  

Public domain, public interest, public funding

, 2005
Charlotte Waelde and Mags McGinley, Public Domain; Public Interest; Public Funding: focussing on the 'three Ps' in scientific research, SCRIPT-ed, March 2005. Abstract (only at the archived edition): 'The purpose of this paper is to discuss the "three Ps" of scientific research: Public Domain; Public Interest ...
openaire   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source